Metformin suppresses growth hormone-mediated PDK4 expression via an AMP-activated protein kinase (AMPK)-SHP pathway [9] and improves fatty liver disease in ob/ob mice [10]. This evidence concerns the gene PDK4 and fatty liver disease.